Free Essay

Pharmaceutical Drugs and Drug Companies

In: Business and Management

Submitted By ngaevo
Words 536
Pages 3
It depends on how you look at it, some people conceder drug companies to be monopolistically competitive but I think it is an oligopoly. Oligopoly is a market structure with significant barriers of entry and exit, many consumers and few firms. With a close look of the drug business you will realize that is it has all the characteristics of an oligopoly started above. Because of the fewer number of firms there is always the tendency of collision, secondly in a relatively un-concentrated market barriers to entry and may simply reflect high operating cost. The high cost of getting this product to the market include clinical trials, patent approval and FDA approval; industry-financed studies claimed $114 million 1987, later went up to $231 million, $403 million, and then $2.1 billion in 2006 for FDA approval, patent approval and clinical trials. Oligopolies in most cases tend to go multinational which is largely associated with todays’ drug companies.
In terms of research and development, I will say it is the backbone of the pharmaceutical industry which makes it very important. I will want to focus on Pfizer one of the big names in this industry. Pfizer’s Global Research and Development is probably the group that the company takes the most pride in for obvious reasons. If we take a broader look at R&D we will see the role and importance of Contract Research Organizations (CROs). CROs account for about 20 percent of drug companies' traditional development business, according to Graham Hughes, a founder and scientific director of Technomark Consulting Services, a London-based firm that has specialized in CROs since 1987. The majority of the CROs' work is in managing Phase I to IV clinical trials, and CROs carry out between 20 and 25 percent of this function a cross the industry—though others put the number for CRO clinical trial management at between 40 and 50 percent. There are roughly 1300 CROs worldwide. About 20 of them have sales exceeding $50 million annually, and for some, revenues exceed $500 million, giving them R&D departments comparable to or larger than those of many of their sponsors, says Mr. Hughes. The global market for CROs is estimated at $8.5 billion according to Arthur D. Little (ADL) and Associates, a Cambridge, Mass.-based consultancy. Of this total, clinical work accounts for $5 billion. Research, including biotech research alliances, accounts for $1.5 billion. Clinical manufacturing controls account for $1.5 billion, and regulatory services, pharmacology and toxicology, represent roughly $800 million. With all this billions of dollars spent on R&B you will never under-state the importance. Researchers have produced breakthroughs in research areas, including HIV infection, hypertension, depression, high cholesterol and many more. The movement from patent drug to a generic drug always have effect on the market. Since prices of generic drugs cost less, there will be a decline in demand for patent drugs, and it may ultimately tend to drive down the cost for the patent brand. In this type of market structure strategic behavior is very important.

Naude, A. (1999). Contract Research Organizations Grow from the Core. Chemical Market Reporter, 256(7), fr17.

Similar Documents

Premium Essay

Pharmaceutical Companies and the Availability of Hiv Drugs to African Countries

...1) Is the monopoly on patented pharmaceuticals warranted? What barrier to entry prevents the re-importation into the United States of pharmaceuticals sold at lower prices abroad (say, in Canada)? Pharmaceutical companies try to maintain a monopoly in the early stages of a drug in order to recover R&D investment. During this period of exclusivity they will try to make a fair profit. This is not a monopoly in the true sense of the word because this period is limited in time. It is perhaps better to describe it as a limited warranty. There are also other limitations. Pharmaceutical companies in some countries may not respect intellectual property and may copy or produce generic drugs even before the patent expires. An important criterion of a monopoly is price control. However, in many countries, a governmental agency is responsible for setting the prices of drugs, making the influence of the manufacturers somewhat limited. This puts pressure on the manufacturers to seek overseas markets in order to maximize their chances of recovering R&D costs and to earn a profit within the period covered by the patent. By so doing the market for re-importation and parallel imports is opened. Some of the prices that the pharmaceutical manufacturers end up accepting under these circumstances do not define a true monopoly. There are several barriers to entry that prevents re-importation into the US of drugs sold at lower prices. These include the following: Price difference ...

Words: 858 - Pages: 4

Premium Essay

Anti-Cancer Drug Cost Regulations- Cocontainment for the Pharmaceutical Companies

...Anti-Cancer Drug Cost Regulations- Cost-Containment for the Pharmaceutical Companies Brenda Roberson University of Maryland University College Abstract Drug development is a long, inefficient, and expensive process and takes 10 to 15 years for development at a cost of about $1.3 billion (Nelson, 2014). When speaking of research and development (R&D) for new drugs; a large number of drugs that go through research do not make it to the FDA or the marketplace. Critics of pharmaceutical companies point out that only a small portion of the pharmaceutical companies’ expenditures account for research and development (R&D). The majority of the money’s spent in marketing and administration. There is also controversy over the $1.3 billion figure as an actual cost. Reported by Nelson (2014) Dr. Kantarjian of M.D. Anderson disputes the $1.3 billion figure for development; he believes this figure to be inflated to cover ancillary expenses, salaries, bonuses, stock market returns, and other indirect costs not related to R&D. The cost of cancer drug therapy is becoming impossible to justify or rationalize for both patient and society. New cancer drugs being approved by the Food and Drug Administration (FDA) are typically costing upwards of $100,000 per year and many times used in combination with other agents (Bunnell, 2012, p. 932) increasing the cost even more. These high priced anti-cancer drugs achieve only marginal benefit for the patient. Benefits achievements of...

Words: 2794 - Pages: 12

Premium Essay

Strategic Managment

...CASE 1 : THE GLOBAL PHARMACEUTICAL INDUSTRY : SWALLOWING A BETTER PILL 1. INTRODUCTION The global pharmaceutical industry is a multinational industry that develops, manufactures, and sells drugs licensed for the treatment. Pharmaceutical companies can sell generic or patent medicines. Health products of the pharmaceutical industry is very often found on the market in the world so that makes the brand of the pharmaceutical industry they are known in the world because of the many products sold are certainly many benefits. As we know there are many companies working in this field. Among the companies that are well known, namely Bayer Healthcare, Johnson & Johnson, Pfizer, Novartis, Hoffmann-La Roche, GlaxoSmithKline, Sanofi-Aventis and many more. The names of these companies are not necessarily familiar to the public. Among the names of global pharmaceutical companies are already very well known, many of which are based in United States. With reasonable price, not too expensive or cheap and very easy to find. Medicinal products from global pharmaceutical companies to be very favorite countries in the world. But of course if explored further, something will have positive and negative, strengths and weaknesses also have external influences whether it be an opportunity or a threat. In this paper will explain a little about the SWOT analysis of the global pharmaceutical companies along with solutions and recommendations. 2. SWOT Analysis SWOT analysis is the......

Words: 1624 - Pages: 7

Premium Essay


...GCC Pharmaceutical Industry March 31, 2013 Alpen Capital was awarded the “Best Research House” at the Banker Middle East Industry Awards 2011 GCC Pharmaceutical Sector | March 31, 2013 Page | 2 Table of Contents 1. 1.1. 1.2. 1.3. 1.4. EXECUTIVE SUMMARY............................................................................ 6 Scope of the Report .................................................................................. 6 Key Growth Drivers .................................................................................. 6 Key Challenges ........................................................................................ 6 Trends .................................................................................................... 7 2. 2.1 2.2 2.3 2.4 2.5 2.6 2.7 GCC PHARMACEUTICAL INDUSTRY OVERVIEW ...................................... 8 GCC Pharmaceutical Market Overview ............................................................. 8 The UAE Pharmaceutical Market .................................................................... 11 The Saudi Arabian Pharmaceutical Market ...................................................... 13 The Kuwaiti Pharmaceutical Market ............................................................... 15 The Qatari Pharmaceutical Market ................................................................. 16 The Bahraini Pharmaceutical Market .............................................................. 17 The...

Words: 27542 - Pages: 111

Premium Essay

Unethical Marketing of Prescription Drugs

...Unethical Marketing of Prescription Drugs: Misleading Direct-To-Consumer Advertising and Disease Mongering. October 3, 2011 Unethical Marketing of Prescription Drugs Introduction The purpose of this ethical paper is to investigate the marketing tactics being used by pharmaceutical companies and discuss the ethical issues involved. The primary source of information discussed in this paper was gathered from analysis of business and scholar journals, case studies, and current news articles. The main focus of my research was placed on the unethical practices of pharmaceutical companies and the current marketing regulations in the United States. The unethical practices primarily covered in this paper include disease/fear mongering, and the misuse of direct-to-consumer & physician-directed marketing to increase the profits of pharmaceutical firms. But before we get into the unethical practices taking place in today’s pharmaceutical industry, let’s take a look at the idea of ethics. So, what exactly is ethics? Merriam-Webster defines ethics as “the discipline dealing with what is good and bad and with moral duty and obligation,” and “a theory or system of moral values” (Merriam-Webster, 2011). As you can see, this is a complex but vague definition to say the least. In today’s world of international business where firms operate across cultural boundaries and face stiff competition in the fight for profits, it’s even more difficult to clearly define the meaning......

Words: 3386 - Pages: 14

Premium Essay

Liminting Big Pharma's Power

...of the pharmaceutical industry with regards to its influence in Washington. By exerting so much influence in the arena where the drug laws are drawn up, discussed, and passed, the pharmaceutical industry, also known as BIG Pharma due to their scope, size, and influence, has negatively affected the consumer in its market, namely the medical patient. The drug industry has done this through lobbying in Washington to keep laws relating to the pharmaceutical market favorable for the drug companies themselves. This brief examines three possible solutions to this problem: lobbying spending and lobbyist limits for pharmaceutical companies, a ban on direct advertisements by pharmaceutical companies, and more transparency and screening before prescribing prescription pain killers. In this analysis, the first alternative represents the best solution to this problem as it has the highest overall potential for benefit and less total cost than the other two possible solutions. Introduction/Background This policy brief examines the pharmaceutical industry and how it has come to gain too much power not only with regards to market power in its industry but also with regards to their influence in Washington. By having this much power, drug companies have negatively affected medical consumers/patients through continued increased prices and a steady decline in innovation. Steps need to be taken to eradicate this problem by reducing the scope of influence of large pharmaceutical......

Words: 3199 - Pages: 13

Premium Essay

Pharmaceutical Industry

...real threats for Pharmaceutical industry as these movements focus on green environments and reduce chemicals and carbon which comes from pharmaceutical industries. It is not being possible to ignore these issues as they are supposed to be practiced under United Nation charter for clean and better environment. For example Pfizer is a well reputed British Pharmaceutical company which has aims to save the environment as much as possible from chemicals, waste water which includes active pharmaceutical ingredients mixture of different compounds and carbon which comes from their pharmaceutical industries. Different strategies could be used to reduce carbon and chemical waste from drugs for human environment, like proper consumption ,good way of savages for hospitals waste water like advance waste water treatment technology, private house hold expire drugs, training and education of medical professionals to reduce over prescription, and public education and awareness. These strategies could be help full for save green house environment from drugs. In conclusion if we do focus on three principal strategies to reduce the input of chemicals compounds, carbon, and waste water in to the environment are substitution of complex chemical compounds, advance technical approach, and proper education and training of doctors, retailers and consumers. (Klaus Kümmerer, 2009) Social The social life, physical activities and level of health of a community affects the pharmaceutical industry.......

Words: 1468 - Pages: 6

Premium Essay

The Food and Drug Administration

...The Food and Drug Administration, also known as the FDA or USFDA, is responsible for protecting and advocating public health. They are the official government agency that ensures our drug supply is safe and effective. This is achieved through the regulation and supervision of food safety, dietary supplements, veterinary products, cosmetics, vaccines, biopharmaceuticals, medical devices, prescription and pharmaceutical drugs that can be purchased over- the- counter. When a pharmaceutical company creates a new drug, it has to go through the FDA and is required to submit a New Drug Application (NDA) to the FDA. The FDA reviews the application to assure that there is an objective proof that the proposed drug is safe and effective. If the drug proves to be effective and safe, the FDA will approve it. However, the FDA requires some drugs to be furthered studied and require additional clinical trials. When the drug is officially approved, the FDA sends an approval letter to the company- this process may take many years. Some important steps taken for an approval are (2008 Internet Drug News Inc.): Synthesis & Purification - FDA estimates that it takes approximately eight-and-a-half years to study and test a new drug before it can be approved for the general public. This estimate includes early laboratory and animal testing, as well as later clinical trials using human subjects. Animal Testing (short term) - Generally, two or more species (one rodent, one non-rodent) are......

Words: 877 - Pages: 4

Premium Essay

Indian Pharma Industry

...analysis: What are acute and chronic ailments? What is the proportion of drugs for each segment in the total domestic formulations market? How have various therapeutic categories in the domestic formulation market performed over the last three years? Publish Date: 15-Jul-2013 | | Majority of ailments in India are more acute than chronic in nature   Types of ailments Source: CRISIL Research Ailments can be classified into acute and chronic. Acute ailments are characterised by sudden, severe exposure (usually a single, large exposure) and rapid onset of the disease. The patient shows intense symptoms for a brief duration (not longer than 30 days). Infectious diseases such as common cold, fever, etc are some examples of acute ailments. However, some acute ailments may turn chronic if left unaddressed. Chronic ailments are characterised by prolonged or repeated exposures over many days, months or years.  Chronic diseases can only be alleviated through treatments, but not fully cured. Unlike acute ailments, they do not usually resolve on their own accord. Examples of chronic diseases include diabetes, asthma, blood pressure, cancer, etc. Due to relatively poor sanitation facilities, India has a greater share of acute diseases than chronic diseases, as compared to developed countries. Thus, drugs addressing acute diseases dominate the domestic pharmaceutical market. About 68 per cent of total drugs sold are used to treat acute diseases. Domestic formulation......

Words: 12248 - Pages: 49

Premium Essay

Organizational Environment & Stakeholders well as the performance of the organization. For our assignment we have chosen Sharif Pharmaceuticals Ltd. Specific Environment: The specific environment includes external forces that directly impact the manager’s decisions and actions and that are directly relevant to the achievement of the organization’s goal. Specific environment includes: • Customers: Every organization needs to deal with their potential customers carefully as they are the ones who will be using their output. The customers of Sharif Pharmaceuticals include- hospitals/clinics all over the country, physicians and most obviously the patients from all walks of life. • Suppliers: For Sharif Pharmaceuticals their suppliers need to have high quality raw materials and provide the company with the lowest possible time and deliver them on time. Otherwise, their business would be hampered. Some of the suppliers of Sharif pharma are: I. Brother’s Trade House Ltd. II. Classic Marketing of Mark Industries III. Dowla Brothers and Company IV. G. S. Enterprise • Competitors: The competitors of an organization can largely affect the sales and profit. So, the competitors should be given adequate importance. The competitors of Sharif Pharmaceuticals are: I. Delta Pharma Ltd II. ACI Ltd. III. Incepta pharmaceuticals Ltd. IV. Square Pharmaceuticals Ltd. V. Apex Pharma Ltd. • Pressure Groups: Pressure groups attempt......

Words: 1744 - Pages: 7

Free Essay


...Cracks in the Pharmaceutical Supply Chain Print Article Close Window From: Cracks in the Pharmaceutical Supply Chain – Susannah Patton, CIO January 15, 2006 As an undercover agent with the Drug Enforcement Administration and the Food and Drug Administration, Aaron Graham saw firsthand how counterfeit drugs can slip into the pharmaceutical supply chain. Graham, now VP and chief security officer for Purdue Pharma, once posed as the manager of an "institutional pharmacy" selling drugs at a discount to secondary wholesalers who were then supposed to sell them to nursing homes. Soon after he began, his phone started ringing. Dozens of smaller pharmaceutical wholesale companies were calling, desperate to buy his drugs. These secondary or "gray market" wholesalers scour the country and the world for low-price drugs they can sell back to major wholesalers for a profit. In addition to trawling for institutional pharmacies, some secondary wholesalers have been known to purchase counterfeit drugs from criminal organizations in places such as China, Thailand or Colombia. Graham, who was part of a two-year FDA sting operation known as "operation gray pill," helped expose a system in which large and small wholesalers were taking advantage of multitiered pricing in the industry. Prescription drugs are sold at discounts to subsidized groups such as nursing homes and also exported at lower prices. Graham and his colleagues......

Words: 3359 - Pages: 14

Premium Essay

International Management

...| Pharmaceutical companies | Research Paper | | Daren Smith | 5/21/2012 | | Abstract There is a lot of discussion about pharmaceutical companies, intellectual property, and the global AIDS epidemic. Do pharmaceutical companies have a responsibility to distribute drugs for free or low cost in developing countries? Why is intellectual property such a big deal? What impact would South Africa’s decision to levy duties on drugs in the country have on the international distribution of drugs? Was the change that provided patent protection for pharmaceutical companies an appropriate change or a dangerous precedent? Was it necessary to relax intellectual property rules in order to ensure that adequate supplies of AIDs medications would be available for distribution in the developing world? What role to multi-national corporations have in providing funding or other assistance to international organizations such as the Global Fund? All these questions have many arguments for and against but the right answers probably lie somewhere in between. Having and providing access to affordable medication is one of the greatest challenges we face in today’s world. Many people see that pharmaceutical companies are irresponsible. The evidence is in the high prices individuals have to pay for medications. Although I don’t care for higher priced medications I do believe in the right for a business, or individual, to make money. To come up with medications it......

Words: 2390 - Pages: 10

Premium Essay

International Business

...Applying Porter’s Five Forces to Pharmaceutical Industry in Egypt The power of buyers is the impact that customers have on a producing industry. Like in any pharmaceutical industry throughout the world, key buyers from the manufacturers distributors of the products, which are mainly hospitals, pharmacies, general stores, and supermarkets (El-Khatib, 2011). The Egyptian pharmaceutical market is fairly fragmented with the pharmacies and drugstores forming the most important distribution channel for medicines in this market. The small independent pharmacies and drugstores have less buyer power than the larger supermarkets and general store chains. Also, large pharmaceutical companies with recognized brands have considerable power over smaller drugstores and pharmacies, thus reducing the buyer power. Usually retailers have significant power in supply chains, but consumer preference also has a significant part in this market. Of course drugs and medicines are much more important to the life of a pharmacy or drugstore than a supermarket; therefore, buyers’ switching costs can differ slightly in this market. If any backward integration happens, it increases pressure on the manufacturing pharmaceutical companies and increases buyer power at the same time. So, overall buyer power is moderate to weak. Suppliers to the pharmaceutical market are mainly the active pharmaceutical ingredients (API) manufacturers. The drug manufacturing companies, who are the main players in this......

Words: 856 - Pages: 4

Premium Essay

Case Analysis Teva Pharmaceuticals

...Teva Pharmaceutical Industries, Ltd 1) External Environment: The Pharmaceutical Industry is dependent on political and legal conditions of general environment. In pharmaceutical industry we have two kind of medications which are generic or innovative. Innovative pharmaceutical industry success depends on the patent protection in the industry. For example, in United States innovative industry can have 10 to 12 years of patent protection life from the time that product is for sale in the market. Success of the generic pharmaceuticals which are bioequivalent to innovative pharmaceutical is also related to the political and legal environment of their market. If we look at pharmaceutical industry globally we can see that regulations toward generic pharmaceutical are different in different countries. For example, in United States they have the Hatch-Waxman ACT 1984including Abbreviated New Drug Application which reduce the drugs approval period and give the chance to Generic companies to have a 180 day exclusivity period if the generic company can submit an abbreviated new drug application before other generic competitors. In Europe regulations are different in each country for example, United Kingdom and the Netherlands are very similar to USA, and countries such as Germany and France are more physician-driven or branded generics market and the cost of sale for generic products are higher in these countries. Market for generic drugs in the rest of...

Words: 1493 - Pages: 6

Free Essay

Business Research Ehtics

...commercial pharmaceutical industry of the United States. In this article the author highlights some market strategies used by the industry, which suggest corrupt practices. The article criticizes the actions of the pharmaceutical industry beginning in the 1980s to the present, asserting that the industry compromises the integrity of the process of medical research and that it pressures consumers and doctors to use its products and that it falsifies data regarding the capabilities and dangers of its drugs (Harriet A. Washington, American Scholar, Summer 2011, vol. 80). Drug makers do not just comprise doctors; they also undermine the top medical journals and skew the findings of medical research. Identifying unethical business research involved in this article is given. Evaluating the article will also show how unethical behavior affects the industry, injured party, and society. A proposition of how unethical behavior can be avoided is proposed. The article is based on how pharmaceutical companies use medical research in medical journals and advertising (Washington H., 2011). Medical advertising has an influence on medical articles in medical journals along with supplying journals with financial support to keep publishing (Washington H., 2011). Health care professionals use medical journals when diagnosing and treating patients. This is not the only issue the article speaks about. Pharmaceutical companies also use techniques in the medical research of drugs to supply......

Words: 796 - Pages: 4